Loading…

Association of Low Maternal Pregnancy-associated Plasma Protein A with Adverse Perinatal Outcome

The aim is to provide an overall view of the association of low pregnancy-associated plasma protein A (PAPP-A) levels with adverse perinatal outcomes. The available literature in PubMed/Medline regarding PAPP-A and adverse pregnancy outcomes was searched for related articles, including terms such as...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2019-06, Vol.11 (6), p.e4912-e4912
Main Authors: Antsaklis, Panagiotis, Fasoulakis, Zacharias, Theodora, Marianna, Diakosavvas, Michail, Kontomanolis, Emmanuel N
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c339t-828c0b200f314beea412719fb8b09b46d52796a196e831d78f9ea5552d13d1263
cites
container_end_page e4912
container_issue 6
container_start_page e4912
container_title Curēus (Palo Alto, CA)
container_volume 11
creator Antsaklis, Panagiotis
Fasoulakis, Zacharias
Theodora, Marianna
Diakosavvas, Michail
Kontomanolis, Emmanuel N
description The aim is to provide an overall view of the association of low pregnancy-associated plasma protein A (PAPP-A) levels with adverse perinatal outcomes. The available literature in PubMed/Medline regarding PAPP-A and adverse pregnancy outcomes was searched for related articles, including terms such as "PAPP-A," "intrauterine growth restriction (IUGR)," "small for gestational age (SGA)," "stillbirth," "adverse outcome," and others. The fifth percentile is supported by many recent studies to be PAPP-A's cutoff for adverse outcome detection and the increased risk seems to be extremely high below 0.2 PAPP-A MoM (multiple of the median). Apart from chromosomal abnormalities, preeclampsia, intrauterine fetal demise, and pregnancy loss have been associated with maternal serum PAPP-A. For results below the first centile, PAPP-A has a strong positive predictive value for SGA and IUGR. Except for its vital role on the cleavage of insulin-like growth factor binding proteins (IGFBP), PAPP-A has proven to be a reliable marker for prenatal screening. Even though PAPP-A as a single predictor proved to be valuable for the prediction of some adverse perinatal outcomes, in some cases, a combination of PAPP-A to other maternal serum markers led to an increase in detection rates. PAPP-A is a promising maternal serum marker for pregnancy outcome prediction with more studies needed in order for its potentials to be fully understood and exploited.
doi_str_mv 10.7759/cureus.4912
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6692091</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2283091411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-828c0b200f314beea412719fb8b09b46d52796a196e831d78f9ea5552d13d1263</originalsourceid><addsrcrecordid>eNpdkV1LHDEUhoNUumK96r0EelMoY_MxH8lNYZFWhS3uhV7HTOaMZplJbJJR_PfNsOuy7VUC5zkPL-dF6DMlF01Tye9mCjDFi1JSdoROGK1FIagoPxz8F-gsxg0hhJKGkYZ8RAtOS8a5kCfoYRmjN1Yn6x32PV75V_xbJwhOD3gd4NFpZ94KvaOgw-tBx1HnmU9gHV7iV5ue8LJ7gRABryFYp1Nevp2S8SN8Qse9HiKc7d5TdP_r593ldbG6vbq5XK4Kw7lMhWDCkJYR0udsLYAuKWuo7FvREtmWdVexRtaayhoEp10jegm6qirWUd5RVvNT9GPrfZ7aEToDLgU9qOdgRx3elNdW_Ttx9kk9-hdV15IRSbPg604Q_J8JYlKjjQaGQTvwU1SM5XuXma4y-uU_dOOn-WIzJXi2lXQWfttSJvgYA_T7MJSouTy1LU_N5WX6_DD_nn2viv8FUqqWbg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2283091411</pqid></control><display><type>article</type><title>Association of Low Maternal Pregnancy-associated Plasma Protein A with Adverse Perinatal Outcome</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Antsaklis, Panagiotis ; Fasoulakis, Zacharias ; Theodora, Marianna ; Diakosavvas, Michail ; Kontomanolis, Emmanuel N</creator><creatorcontrib>Antsaklis, Panagiotis ; Fasoulakis, Zacharias ; Theodora, Marianna ; Diakosavvas, Michail ; Kontomanolis, Emmanuel N</creatorcontrib><description>The aim is to provide an overall view of the association of low pregnancy-associated plasma protein A (PAPP-A) levels with adverse perinatal outcomes. The available literature in PubMed/Medline regarding PAPP-A and adverse pregnancy outcomes was searched for related articles, including terms such as "PAPP-A," "intrauterine growth restriction (IUGR)," "small for gestational age (SGA)," "stillbirth," "adverse outcome," and others. The fifth percentile is supported by many recent studies to be PAPP-A's cutoff for adverse outcome detection and the increased risk seems to be extremely high below 0.2 PAPP-A MoM (multiple of the median). Apart from chromosomal abnormalities, preeclampsia, intrauterine fetal demise, and pregnancy loss have been associated with maternal serum PAPP-A. For results below the first centile, PAPP-A has a strong positive predictive value for SGA and IUGR. Except for its vital role on the cleavage of insulin-like growth factor binding proteins (IGFBP), PAPP-A has proven to be a reliable marker for prenatal screening. Even though PAPP-A as a single predictor proved to be valuable for the prediction of some adverse perinatal outcomes, in some cases, a combination of PAPP-A to other maternal serum markers led to an increase in detection rates. PAPP-A is a promising maternal serum marker for pregnancy outcome prediction with more studies needed in order for its potentials to be fully understood and exploited.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.4912</identifier><identifier>PMID: 31423389</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Biomarkers ; Clinical outcomes ; Health risk assessment ; Insulin-like growth factors ; Miscarriage ; Obstetrics/Gynecology ; Pediatrics ; Plasma ; Preeclampsia ; Pregnancy ; Pregnancy complications ; Preventive Medicine ; Proteins ; Stillbirth ; Womens health</subject><ispartof>Curēus (Palo Alto, CA), 2019-06, Vol.11 (6), p.e4912-e4912</ispartof><rights>Copyright © 2019, Antsaklis et al. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2019, Antsaklis et al. 2019 Antsaklis et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-828c0b200f314beea412719fb8b09b46d52796a196e831d78f9ea5552d13d1263</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2283091411/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2283091411?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31423389$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Antsaklis, Panagiotis</creatorcontrib><creatorcontrib>Fasoulakis, Zacharias</creatorcontrib><creatorcontrib>Theodora, Marianna</creatorcontrib><creatorcontrib>Diakosavvas, Michail</creatorcontrib><creatorcontrib>Kontomanolis, Emmanuel N</creatorcontrib><title>Association of Low Maternal Pregnancy-associated Plasma Protein A with Adverse Perinatal Outcome</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>The aim is to provide an overall view of the association of low pregnancy-associated plasma protein A (PAPP-A) levels with adverse perinatal outcomes. The available literature in PubMed/Medline regarding PAPP-A and adverse pregnancy outcomes was searched for related articles, including terms such as "PAPP-A," "intrauterine growth restriction (IUGR)," "small for gestational age (SGA)," "stillbirth," "adverse outcome," and others. The fifth percentile is supported by many recent studies to be PAPP-A's cutoff for adverse outcome detection and the increased risk seems to be extremely high below 0.2 PAPP-A MoM (multiple of the median). Apart from chromosomal abnormalities, preeclampsia, intrauterine fetal demise, and pregnancy loss have been associated with maternal serum PAPP-A. For results below the first centile, PAPP-A has a strong positive predictive value for SGA and IUGR. Except for its vital role on the cleavage of insulin-like growth factor binding proteins (IGFBP), PAPP-A has proven to be a reliable marker for prenatal screening. Even though PAPP-A as a single predictor proved to be valuable for the prediction of some adverse perinatal outcomes, in some cases, a combination of PAPP-A to other maternal serum markers led to an increase in detection rates. PAPP-A is a promising maternal serum marker for pregnancy outcome prediction with more studies needed in order for its potentials to be fully understood and exploited.</description><subject>Biomarkers</subject><subject>Clinical outcomes</subject><subject>Health risk assessment</subject><subject>Insulin-like growth factors</subject><subject>Miscarriage</subject><subject>Obstetrics/Gynecology</subject><subject>Pediatrics</subject><subject>Plasma</subject><subject>Preeclampsia</subject><subject>Pregnancy</subject><subject>Pregnancy complications</subject><subject>Preventive Medicine</subject><subject>Proteins</subject><subject>Stillbirth</subject><subject>Womens health</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkV1LHDEUhoNUumK96r0EelMoY_MxH8lNYZFWhS3uhV7HTOaMZplJbJJR_PfNsOuy7VUC5zkPL-dF6DMlF01Tye9mCjDFi1JSdoROGK1FIagoPxz8F-gsxg0hhJKGkYZ8RAtOS8a5kCfoYRmjN1Yn6x32PV75V_xbJwhOD3gd4NFpZ94KvaOgw-tBx1HnmU9gHV7iV5ue8LJ7gRABryFYp1Nevp2S8SN8Qse9HiKc7d5TdP_r593ldbG6vbq5XK4Kw7lMhWDCkJYR0udsLYAuKWuo7FvREtmWdVexRtaayhoEp10jegm6qirWUd5RVvNT9GPrfZ7aEToDLgU9qOdgRx3elNdW_Ttx9kk9-hdV15IRSbPg604Q_J8JYlKjjQaGQTvwU1SM5XuXma4y-uU_dOOn-WIzJXi2lXQWfttSJvgYA_T7MJSouTy1LU_N5WX6_DD_nn2viv8FUqqWbg</recordid><startdate>20190617</startdate><enddate>20190617</enddate><creator>Antsaklis, Panagiotis</creator><creator>Fasoulakis, Zacharias</creator><creator>Theodora, Marianna</creator><creator>Diakosavvas, Michail</creator><creator>Kontomanolis, Emmanuel N</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190617</creationdate><title>Association of Low Maternal Pregnancy-associated Plasma Protein A with Adverse Perinatal Outcome</title><author>Antsaklis, Panagiotis ; Fasoulakis, Zacharias ; Theodora, Marianna ; Diakosavvas, Michail ; Kontomanolis, Emmanuel N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-828c0b200f314beea412719fb8b09b46d52796a196e831d78f9ea5552d13d1263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Biomarkers</topic><topic>Clinical outcomes</topic><topic>Health risk assessment</topic><topic>Insulin-like growth factors</topic><topic>Miscarriage</topic><topic>Obstetrics/Gynecology</topic><topic>Pediatrics</topic><topic>Plasma</topic><topic>Preeclampsia</topic><topic>Pregnancy</topic><topic>Pregnancy complications</topic><topic>Preventive Medicine</topic><topic>Proteins</topic><topic>Stillbirth</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Antsaklis, Panagiotis</creatorcontrib><creatorcontrib>Fasoulakis, Zacharias</creatorcontrib><creatorcontrib>Theodora, Marianna</creatorcontrib><creatorcontrib>Diakosavvas, Michail</creatorcontrib><creatorcontrib>Kontomanolis, Emmanuel N</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Antsaklis, Panagiotis</au><au>Fasoulakis, Zacharias</au><au>Theodora, Marianna</au><au>Diakosavvas, Michail</au><au>Kontomanolis, Emmanuel N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of Low Maternal Pregnancy-associated Plasma Protein A with Adverse Perinatal Outcome</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2019-06-17</date><risdate>2019</risdate><volume>11</volume><issue>6</issue><spage>e4912</spage><epage>e4912</epage><pages>e4912-e4912</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>The aim is to provide an overall view of the association of low pregnancy-associated plasma protein A (PAPP-A) levels with adverse perinatal outcomes. The available literature in PubMed/Medline regarding PAPP-A and adverse pregnancy outcomes was searched for related articles, including terms such as "PAPP-A," "intrauterine growth restriction (IUGR)," "small for gestational age (SGA)," "stillbirth," "adverse outcome," and others. The fifth percentile is supported by many recent studies to be PAPP-A's cutoff for adverse outcome detection and the increased risk seems to be extremely high below 0.2 PAPP-A MoM (multiple of the median). Apart from chromosomal abnormalities, preeclampsia, intrauterine fetal demise, and pregnancy loss have been associated with maternal serum PAPP-A. For results below the first centile, PAPP-A has a strong positive predictive value for SGA and IUGR. Except for its vital role on the cleavage of insulin-like growth factor binding proteins (IGFBP), PAPP-A has proven to be a reliable marker for prenatal screening. Even though PAPP-A as a single predictor proved to be valuable for the prediction of some adverse perinatal outcomes, in some cases, a combination of PAPP-A to other maternal serum markers led to an increase in detection rates. PAPP-A is a promising maternal serum marker for pregnancy outcome prediction with more studies needed in order for its potentials to be fully understood and exploited.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>31423389</pmid><doi>10.7759/cureus.4912</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2019-06, Vol.11 (6), p.e4912-e4912
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6692091
source Publicly Available Content (ProQuest); PubMed Central
subjects Biomarkers
Clinical outcomes
Health risk assessment
Insulin-like growth factors
Miscarriage
Obstetrics/Gynecology
Pediatrics
Plasma
Preeclampsia
Pregnancy
Pregnancy complications
Preventive Medicine
Proteins
Stillbirth
Womens health
title Association of Low Maternal Pregnancy-associated Plasma Protein A with Adverse Perinatal Outcome
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T00%3A56%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20Low%20Maternal%20Pregnancy-associated%20Plasma%20Protein%20A%20with%20Adverse%20Perinatal%20Outcome&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Antsaklis,%20Panagiotis&rft.date=2019-06-17&rft.volume=11&rft.issue=6&rft.spage=e4912&rft.epage=e4912&rft.pages=e4912-e4912&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.4912&rft_dat=%3Cproquest_pubme%3E2283091411%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c339t-828c0b200f314beea412719fb8b09b46d52796a196e831d78f9ea5552d13d1263%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2283091411&rft_id=info:pmid/31423389&rfr_iscdi=true